Please login to the form below

Not currently logged in
Email:
Password:

NOAC

This page shows the latest NOAC news and features for those working in and with pharma, biotech and healthcare.

CHMP backs Lynparza in breast cancer, Dupixent in asthma

CHMP backs Lynparza in breast cancer, Dupixent in asthma

be the first reversal agent for novel oral anticoagulants (NOACs) that target factor Xa. ... So far, Boehringer Ingelheim’s rival NOAC Pradaxa (dabigatran) - which works by inhibiting thrombin - is the only NOAC on the market with a reversal agent

Latest news

More from news
Approximately 11 fully matching, plus 21 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • NOAC Education: Empowering Stroke Prevention

    The use of oral anticoagulants in patients with atrial fibrillation. NOAC reversal agents. ... PCM Scientific is always open to additional sources of funding support to expand the educational offerings of the NOAC education site.

  • Cogora

    PCM Scientific, Cogora’s CME division, developed NOAC Education as an independent educational initiative with a single, central goal: to support clinicians in providing optimal anticoagulation care for patients at risk

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics